(NTLA) Intellia Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Intellia Therapeutics | (NTLA) share price targets
Complete technical analysis of Intellia Therapeutics (NTLA) by charts plus indicators, forecast predictions and share price targets for Intellia Therapeutics (NTLA)
Intellia Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-09-04 View latest technical analysis
10 day averaged volume of Intellia Therapeutics is 1066710
| Date | Daily Closing Price | Open | High | Low | Volume |
| 04 Wed Sep 2024 | 21.27 | 21.72 | 22.15 | 21.07 | 0.818 times |
| 03 Tue Sep 2024 | 21.62 | 22.35 | 23.09 | 21.51 | 1.432 times |
| 30 Fri Aug 2024 | 22.44 | 23.06 | 23.19 | 21.93 | 1.308 times |
| 30 Fri Aug 2024 | 22.44 | 23.06 | 23.19 | 21.93 | 1.312 times |
| 29 Thu Aug 2024 | 23.00 | 22.49 | 23.50 | 22.34 | 0.877 times |
| 28 Wed Aug 2024 | 22.35 | 22.83 | 23.02 | 22.09 | 0.839 times |
| 27 Tue Aug 2024 | 22.94 | 23.52 | 23.62 | 22.68 | 0.619 times |
| 26 Mon Aug 2024 | 23.58 | 23.94 | 24.05 | 23.40 | 0.755 times |
| 23 Fri Aug 2024 | 23.63 | 23.06 | 24.16 | 22.85 | 0.99 times |
| 22 Thu Aug 2024 | 23.00 | 23.64 | 23.67 | 22.87 | 0.813 times |
Although my analysis for stock is bearish for shortterm, but stock is in heavy over sold zones and there are high chances of some recovery tomorrow. You might want to buy the stock tomorrow in intra day with a stoploss of 21, for a target of 21.8 or 22.58
Share price targets for Intellia Therapeutics (NTLA)
| Target Type | Value |
| Downside Target | 20.82 |
| Upside Target | 22.39 |
| Upside Target | 23.09 |
| Upside Target | 23.17 |
| Upside Target | 23.19 |
| Upside Target | 24.05 |
| Upside Target | 24.16 |
| Upside Target | 26.63 |
| Upside Target | 26.98 |
| Upside Target | 27.17 |
| Upside Target | 28.18 |
Intraday share price targets for Intellia Therapeutics (NTLA)
| Target Type | Value |
| Downside Intraday Target | 20.53 |
| Downside Intraday Target | 19.79 |
| Upside Intraday Target | 22.55 |
| Upside Intraday Target | 23.83 |
| Upside Intraday Target | 21.81 |
Weekly technical analysis of Intellia Therapeutics (NTLA)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 04 Wed Sep 2024 | 21.27 | 22.35 | 23.09 | 21.07 | 1.72 times |
| 30 Fri Aug 2024 | 22.44 | 23.06 | 23.19 | 21.93 | 0.297 times |
| 30 Fri Aug 2024 | 22.44 | 23.94 | 24.05 | 21.93 | 0.918 times |
| 23 Fri Aug 2024 | 23.63 | 22.69 | 24.16 | 22.39 | 0.816 times |
| 16 Fri Aug 2024 | 22.65 | 21.54 | 23.17 | 21.01 | 0.889 times |
Price has moved down this week, and volume has increased substantially. This means that the move can continue in coming weeks.
Monthly technical analysis of Intellia Therapeutics (NTLA)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 04 Wed Sep 2024 | 21.27 | 22.35 | 23.09 | 21.07 | 0.088 times |
| 30 Fri Aug 2024 | 22.44 | 26.63 | 26.63 | 20.82 | 0.8 times |
| 31 Wed Jul 2024 | 26.21 | 22.11 | 28.18 | 21.60 | 0.824 times |
| 28 Fri Jun 2024 | 22.38 | 22.60 | 26.98 | 21.78 | 1.295 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Intellia Therapeutics (NTLA)
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a short to mid term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Intellia Therapeutics stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Intellia Therapeutics in short term and the sell signal is strong.
Intellia Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Intellia Therapeutics in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Intellia Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 22.55 and Intellia Therapeutics (NTLA) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Intellia Therapeutics (NTLA) stock. Volume based technical analysis of Intellia Therapeutics (NTLA) stock is negative.
Intellia Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a short to mid term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Intellia Therapeutics stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Intellia Therapeutics in short term and the sell signal is strong.
Intellia Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Intellia Therapeutics in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Intellia Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 22.55 and Intellia Therapeutics (NTLA) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Intellia Therapeutics (NTLA) stock. Volume based technical analysis of Intellia Therapeutics (NTLA) stock is negative.
Intellia Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.